Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Garcion

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Trends in Endocrinology and Metabolism: TEM|May 5, 2015
Iron metabolism: a double-edged sword in the resistance of glioblastoma to therapiesClaire Legendre, Emmanuel Garcion
BMC Cancer|February 3, 2016
Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cellsClaire Legendre, Sylvie Avril, Catherine Guillet, et al.
Journal of Theoretical Biology|August 11, 2004
RNA mutagenesis and sporadic prion diseasesEmmanuel Garcion, Bradley Wallace, Laurent Pelletier, et al.
Cancer Letters|October 17, 2008
Cancer stem cells: beyond Koch's postulatesEmmanuel Garcion, Philippe Naveilhan, François Berger, et al.
Development (Cambridge, England)|July 1, 2004
Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin CEmmanuel Garcion, Aida Halilagic, Andreas Faissner, et al.
Nanomedicine (London, England)|February 13, 2010
Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral deliveryEmilie Roger, Frederic Lagarce, Emmanuel Garcion, et al.
Journal of Nanoscience and Nanotechnology|February 21, 2008
Lipid nanocapsules for intracellular drug delivery of anticancer drugsFranck Lacoeuille, Emmanuel Garcion, Jean-Pierre Benoit, et al.
Trends in Pharmacological Sciences|April 14, 2019
Rethinking Alkylating(-Like) Agents for Solid Tumor ManagementHélène Lajous, Bénédicte Lelièvre, Elodie Vauléon, et al.
Neuro-Oncology Advances|May 27, 2024
Chromothripsis is rare in IDH-mutant gliomas compared to IDH-wild-type glioblastomas whereas whole-genome duplication is equally frequent in both tumor typesBaptiste Sourty, Laëtitia Basset, Alix Fontaine, et al.
Plos One|October 4, 2011
The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cellsErika Bourseau-Guilmain, Audrey Griveau, Jean-Pierre Benoit, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Trends in Endocrinology and Metabolism: TEM|May 5, 2015
Iron metabolism: a double-edged sword in the resistance of glioblastoma to therapiesClaire Legendre, Emmanuel Garcion
BMC Cancer|February 3, 2016
Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cellsClaire Legendre, Sylvie Avril, Catherine Guillet, et al.
Journal of Theoretical Biology|August 11, 2004
RNA mutagenesis and sporadic prion diseasesEmmanuel Garcion, Bradley Wallace, Laurent Pelletier, et al.
Cancer Letters|October 17, 2008
Cancer stem cells: beyond Koch's postulatesEmmanuel Garcion, Philippe Naveilhan, François Berger, et al.
Development (Cambridge, England)|July 1, 2004
Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin CEmmanuel Garcion, Aida Halilagic, Andreas Faissner, et al.
Nanomedicine (London, England)|February 13, 2010
Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral deliveryEmilie Roger, Frederic Lagarce, Emmanuel Garcion, et al.
Journal of Nanoscience and Nanotechnology|February 21, 2008
Lipid nanocapsules for intracellular drug delivery of anticancer drugsFranck Lacoeuille, Emmanuel Garcion, Jean-Pierre Benoit, et al.
Trends in Pharmacological Sciences|April 14, 2019
Rethinking Alkylating(-Like) Agents for Solid Tumor ManagementHélène Lajous, Bénédicte Lelièvre, Elodie Vauléon, et al.
Neuro-Oncology Advances|May 27, 2024
Chromothripsis is rare in IDH-mutant gliomas compared to IDH-wild-type glioblastomas whereas whole-genome duplication is equally frequent in both tumor typesBaptiste Sourty, Laëtitia Basset, Alix Fontaine, et al.
Plos One|October 4, 2011
The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cellsErika Bourseau-Guilmain, Audrey Griveau, Jean-Pierre Benoit, et al.
Pageof 7